- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01381224
Do Lower Spine Injections Improve Outcomes for Lower Back Pain Patients
April 18, 2013 updated by: University of Florida
Do Lumbar Spine Injections Improve Short-Term Biomechanical Outcomes in Patients With Chronic Low Back Pain
The purpose of this project is to determine the effect of lower back injections on select biomechanical outcomes, walking patterns, lower back flexibility and balance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this project is to determine the effect of lumbar injections on select biomechanics parameters; walking pattern, lumbar flexibility and balance.
The surveys will help assess the patient's sense of functional ability and feeling of wellness compared with low back pain scores.
The long terms goals of this project will be to elucidate the mechanism of action of injections and to improve identification of patients that are likely to benefit from injection therapy
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32607
- UF&Shands Orthopaedics and Sports Medicine Institute
-
Gainesville, Florida, United States, 32607
- Shands Rehabilitation Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients receiving a lumbar epidural steroid injection for lumbar spine stenosis
Description
Inclusion Criteria:
- diagnosis of lumbar spine stenosis
- receiving lumbar epidural injection
- age 18-90 years
- BMI <35kg/m2
- walking unaided
Exclusion Criteria:
- age <18 or >90 years
- BMI >35 kg/m2
- severely impaired intellectual capacity
- medications that could impact balance
- dementia, or other neurodegenerative diseases that would preclude appropriate cognitive or physical ability to perform study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Observation of biomechanical effects post injection
Observation of effects on gait, lumbar spine range of motion and pain symptoms immediately following injection and at two weeks post injection.
|
Observation of effects on gait, lumbar spine range of motion and pain symptoms immediately following injection and at two weeks post injection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the immediate biomechanical effect in patients that receive a lumbar epidural injection
Time Frame: Immediately following injection
|
We hypothesize that patients will demonstrate increased gait velocity, increased step length, decreased asymmetry and increased lumbar ROM immediately after injection compared to pre-injection
|
Immediately following injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the short-term biomechanical effect in patients that receive a lumbar epidural injection
Time Frame: Two weeks following injection
|
We hypothesize that patients will demonstrate increased gait velocity, increased step length, decreased asymmetry and increased lumbar ROM 2 weeks after injection compared with pre- and post-injection time points
|
Two weeks following injection
|
|
Determine the relationship between biomechanical status before injection and short-term pain reduction
Time Frame: Two weeks following injection
|
We hypothesize that those patients with moderate biomechanical limitation before injection (e.g., higher gait velocity, higher step length, lower asymmetry, and greater lumbar ROM) will have greater positive biomechanical response than patients who demonstrate severe biomechanical limitation pre-injection.
This response to the injection will be measured by the changes in gait and lumbar spine range of motion and pain symptoms with these activities at 2 weeks after the injection
|
Two weeks following injection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bryan P Conrad, Ph.D., UF Department of Orthopaedics and Rehabilitation
- Principal Investigator: D J Kennedy, M.D., UF Department of Orthopaedics and Rehabilitation
- Principal Investigator: Heather K Vincent, Ph.D., UF Department of Orthopaedics and Rehabilitation
- Principal Investigator: Deepa Sunkari, M.D., UF Department of Orthopaedics and Rehabilitation
- Principal Investigator: Amanda N Seay, B.S., UF Department of Orthopaedics and Rehabilitation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
October 1, 2012
Study Registration Dates
First Submitted
June 22, 2011
First Submitted That Met QC Criteria
June 22, 2011
First Posted (Estimate)
June 27, 2011
Study Record Updates
Last Update Posted (Estimate)
April 22, 2013
Last Update Submitted That Met QC Criteria
April 18, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 629-2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.